Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.

Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, Bueller JA, Suyenobu B, Jarcho JM, McRoberts JA, Niesler B, Mayer EA.

Gastroenterology. 2011 Jun;140(7):1943-51. doi: 10.1053/j.gastro.2011.03.011. Epub 2011 Mar 21.

2.

Impact of Mindfulness-Based Stress Reduction training on intrinsic brain connectivity.

Kilpatrick LA, Suyenobu BY, Smith SR, Bueller JA, Goodman T, Creswell JD, Tillisch K, Mayer EA, Naliboff BD.

Neuroimage. 2011 May 1;56(1):290-8. doi: 10.1016/j.neuroimage.2011.02.034. Epub 2011 Feb 18.

3.

Regional gray matter density changes in brains of patients with irritable bowel syndrome.

Seminowicz DA, Labus JS, Bueller JA, Tillisch K, Naliboff BD, Bushnell MC, Mayer EA.

Gastroenterology. 2010 Jul;139(1):48-57.e2. doi: 10.1053/j.gastro.2010.03.049. Epub 2010 Mar 27.

4.

Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis.

Labus JS, Naliboff BN, Fallon J, Berman SM, Suyenobu B, Bueller JA, Mandelkern M, Mayer EA.

Neuroimage. 2008 Jul 1;41(3):1032-43. doi: 10.1016/j.neuroimage.2008.03.009. Epub 2008 Mar 20.

5.

Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome.

Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Ohning G, Kilpatrick L, Bueller JA, Ruby K, Jarcho J, Mayer EA.

J Neurosci. 2008 Jan 9;28(2):349-59. doi: 10.1523/JNEUROSCI.2500-07.2008.

6.

Functional GI disorders: from animal models to drug development.

Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD.

Gut. 2008 Mar;57(3):384-404. Epub 2007 Oct 26. Review.

7.

Altered central micro-opioid receptor binding after psychological trauma.

Liberzon I, Taylor SF, Phan KL, Britton JC, Fig LM, Bueller JA, Koeppe RA, Zubieta JK.

Biol Psychiatry. 2007 May 1;61(9):1030-8. Epub 2006 Aug 30.

PMID:
16945349
8.

Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.

Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK.

J Neurosci. 2006 May 24;26(21):5777-85.

9.

Sex differences in regional brain response to aversive pelvic visceral stimuli.

Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Bueller JA, Ruby K, Mayer EA.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R268-76. Epub 2006 Apr 13.

10.

BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.

Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK.

Biol Psychiatry. 2006 May 1;59(9):812-5. Epub 2006 Jan 25.

PMID:
16442082
11.

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.

Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS.

J Neurosci. 2005 Aug 24;25(34):7754-62.

12.

Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.

Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA, Koeppe RA.

Arch Gen Psychiatry. 2003 Nov;60(11):1145-53.

PMID:
14609890
13.

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D.

Science. 2003 Feb 21;299(5610):1240-3.

14.

mu-opioid receptor-mediated antinociceptive responses differ in men and women.

Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS.

J Neurosci. 2002 Jun 15;22(12):5100-7.

15.

Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS.

Science. 2001 Jul 13;293(5528):311-5.

Supplemental Content

Loading ...
Support Center